Leukocare Revenue

Biotechnology Research • Planegg, Bavaria, Germany • 51-100 Employees

Leukocare revenue & valuation

Annual revenue	$5,600,000
Revenue per employee	$110,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$18,000,000
Total funding	$2,500,000

Key Contacts at Leukocare

Jarrid Goldstein

Scientific Director, Teamleader R&D

Juergen Lindemeier

Director Business Development Interim

Roland Kirchner

Director Biofunctional Devices

Peter-Jochen Heuberger

Finance Director

Konstadinos Salassidis

Director Bd Marketing And Sales

John Venz

Scientific Associate Director Biostatistics

Company overview

Headquarters	Am Klopferspitz 19a, Planegg, Bayern 82152, DE
Phone number	+494908978016650
Website	leukocare.com
NAICS	541714
SIC	873
Keywords	RNA, Enzymes, Vaccines, Antibodies, Bsl-1, Bsl-2, High Concentration Formulations, Viral Vectors, Proteins, Peptides, Atmp, Molecular Modeling, Exosomes, Viruses, Particle Characterization, Lnps, Colloidal And Conformational Stability Analysis, In-Silico Long-Term Stability Prediction, Lyo Optimization, Molecular Purity And Integrity Analysis, State-Of-The-Art Design Of Experiment Matrices
Founded	2003
Employees	51-100
Socials

Leukocare Email Formats

Leukocare uses 3 email formats. The most common is {first initial}.{last name} (e.g., j.doe@leukocare.com), used 60.9% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@leukocare.com	60.9%
{first name}.{last name}	john.doe@leukocare.com	34.8%
{first initial}.{last name}{last name}	j.doedoe@leukocare.com	4.3%

About Leukocare

For over 20 years, Leukocare has been trusted by pharmaceutical companies, mid-sized biotech firms, and innovative biotechs for our Quality by Design-driven approach to formulation development. Our proven track record includes advancing companies into clinics, filing BLAs, and enabling patent potential, demonstrating our commitment to the successful development of cutting-edge therapies. Our strength lies in combining strong formulation expertise with data science and statistical approaches, ensuring a systematic, evidence-driven path forward. With extensive experience in both liquid and lyophilized formulation development for proteins, monoclonal antibodies (mAbs), viral vectors, and viruses, we are equipped to tackle the most complex challenges combining 100+ regulatory approved excipients. However, our greatest asset is our adaptability. We remain agile, responding quickly to changes in the regulatory landscape and evolving client needs. By combining scientific expertise with a deep understanding of regulatory requirements and the latest industry advancements, we ensure that our clients are always a step ahead. Typical projects include: • Molecular Modeling and Benchmarking • Pre-Formulation • QbD Formulation Development and Optimization • Process Development and Transfer • IP Support We believe that a great formulation is not just about scientific knowledge; it’s about relevant data, an in-depth understanding of regulatory and industry standards, and the ability to adapt quickly to the changing landscape of drug development. Let’s connect to explore how we can help advance your drug product developments. You can reach out by: • Messaging us on LinkedIn to start a conversation. • Visiting our website to learn more about our services and get in touch with our team. • Emailing us directly at info@leukocare.com for personalized support.

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Entry

Manager

Director

Employees by Department

Leukocare has 18 employees across 5 departments.

Departments

Number of employees

Funding Data

Explore Leukocare's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2021-07-23	1	$2,500,000

Funding Insights

$2,500,000

Total funding amount

$2,500,000

Most recent funding amount

Number of funding rounds

Leukocare Tech Stack

Discover the technologies and tools that power Leukocare's digital infrastructure, from frameworks to analytics platforms.

Plesk

Hosting panels

Apache HTTP Server

Web servers

Vue.js

JavaScript frameworks

parcel

Miscellaneous

Google Tag Manager

Tag managers

PHP

Programming languages

Open Graph

Miscellaneous

core-js

JavaScript libraries

Goober

JavaScript libraries

Axios

JavaScript libraries

Google Analytics

Analytics

Mouse Flow

Analytics

Frequently asked questions

Leukocare is located in Planegg, Bavaria, DE.

You can reach Leukocare at +494908978016650.

Leukocare generates an estimated annual revenue of $5,600,000. This revenue figure reflects the company's market position and business performance in its industry.

Leukocare has an estimated valuation of $18,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Leukocare was founded in 2003, making it 23 years old. The company has established itself as a significant player in its industry over this time.

Leukocare has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.

Leukocare has raised a total of $2,500,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Leukocare

Jarrid Goldstein

Scientific Director, Teamleader R&D

Juergen Lindemeier

Director Business Development Interim

Roland Kirchner

Director Biofunctional Devices

Peter-Jochen Heuberger

Finance Director

Konstadinos Salassidis